Warfarin Versus Non-Vitamin K Inhibitors Medications and Cognitive Disease Progression in Atrial Fibrillation.
Kathryn A Wood, Yi-An Ko, Feier Han and 3 others
PMID 39737787WHAT IT FOUND
Warfarin and newer anticoagulants showed no difference in how quickly patients with atrial fibrillation progressed from normal thinking to dementia.
Switching between these drug classes is not supported by evidence of a cognitive benefit.
Key findings
01The primary analysis found no significant association between using non-vitamin K inhibitors versus warfarin and the progression of cognitive decline.
02Adjusting for clinical factors such as age, sex, and comorbidities did not change the finding that there was no significant difference between the two medication groups.
03Participants using non-vitamin K inhibitors had significantly higher education levels than those using warfarin, which may have influenced the results.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study population was predominantly older, non-Hispanic White Americans with higher levels of education, which limits the generalizability of the findings to the broader U.S. population with atrial fibrillation. The database did not contain specific clinical details such as the international normalized ratio (INR) levels for warfarin users, so the quality of anticoagulation control could not be assessed. Medication use was assumed to be constant between visits, which may not accurately reflect real-world adherence or switching patterns. The NOAC group had significantly higher education levels than the warfarin group, which is an independent protective factor against dementia and may have confounded the results.
Declared interests
The study was supported by the National Institute on Aging (U01 AG016976). No other conflicts of interest were reported in the provided text.
The easy way to misread this
Do not interpret the null finding as evidence that anticoagulants do not help prevent cognitive decline overall. The study only compared warfarin to NOACs; it did not compare either drug to no treatment, so it cannot tell you if taking these medications protects the brain compared to not taking them.